PLUS1
2.405
0.195 (8.82%)
0.195 (8.82%)
Upgrade to Real-Time
Regular Market
Low
1.82
High
4.36
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.195 | 8.82% | 2.405 | 11:23:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.32 | 2.295 | 2.47 | 2.21 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.40 | 2.41 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,505 | 914,159 | $ 2.38 | $ 2,172,944 | 1,404,535 | 1.82 - 4.36 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:24:51 | 25 | $ 2.4054 | USD |
Phio Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 32.55M | 13.53M | 13.50M | $ - | $ - | -2.48 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 168.19k | 10.50% |
Phio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.04 | 2.47 | 2.01 | 2.17 | 553,325 | 0.365 | 17.89% |
| 1 Month | 1.89 | 2.47 | 1.82 | 2.14 | 479,472 | 0.515 | 27.25% |
| 3 Months | 3.04 | 3.10 | 1.82 | 2.46 | 904,399 | -0.635 | -20.89% |
| 6 Months | 2.84 | 4.36 | 1.82 | 2.97 | 1,064,112 | -0.435 | -15.32% |
| 1 Year | 2.34 | 4.36 | 1.82 | 2.82 | 774,270 | 0.065 | 2.78% |
| 3 Years | 0.39 | 10.85 | 0.097 | 1.81 | 751,505 | 2.02 | 516.67% |
| 5 Years | 0.39 | 10.85 | 0.097 | 1.81 | 751,505 | 2.02 | 516.67% |
Phio Pharmaceuticals Description
| Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. |
